In re Intuniv Antitrust Litigation, No. 1:16-cv-12653 (D.Mass.)

Radice Law Firm is one of class counsel for direct purchaser plaintiffs in an antitrust action alleging an unlawful scheme by Shire and Actavis to monopolize the market for the ADHD medication Intuniv (guanfacine hydrochloride). The case is pending trial in the U.S. District Court for the District of Massachusetts following the court’s denial of Shire’s motions for summary judgment in October 2020.



Add a Response

Your name, email address, and comment are required. We will not publish your email.

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

The following HTML tags can be used in the comment field: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <pre> <q cite=""> <s> <strike> <strong>

%d bloggers like this: